Skip Navigation
Skip to contents

Ann Coloproctol : Annals of Coloproctology

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
8 "Han Deok Kwak"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Guideline
Colorectal cancer
Colon cancer: the 2023 Korean clinical practice guidelines for diagnosis and treatment
Hyo Seon Ryu, Hyun Jung Kim, Woong Bae Ji, Byung Chang Kim, Ji Hun Kim, Sung Kyung Moon, Sung Il Kang, Han Deok Kwak, Eun Sun Kim, Chang Hyun Kim, Tae Hyung Kim, Gyoung Tae Noh, Byung-Soo Park, Hyeung-Min Park, Jeong Mo Bae, Jung Hoon Bae, Ni Eun Seo, Chang Hoon Song, Mi Sun Ahn, Jae Seon Eo, Young Chul Yoon, Joon-Kee Yoon, Kyung Ha Lee, Kyung Hee Lee, Kil-Yong Lee, Myung Su Lee, Sung Hak Lee, Jong Min Lee, Ji Eun Lee, Han Hee Lee, Myong Hoon Ihn, Je-Ho Jang, Sun Kyung Jeon, Kum Ju Chae, Jin-Ho Choi, Dae Hee Pyo, Gi Won Ha, Kyung Su Han, Young Ki Hong, Chang Won Hong, Jung-Myun Kwak, Korean Colon Cancer Multidisciplinary Committee
Ann Coloproctol. 2024;40(2):89-113.   Published online April 30, 2024
DOI: https://doi.org/10.3393/ac.2024.00059.0008
  • 5,311 View
  • 299 Download
  • 8 Web of Science
  • 8 Citations
AbstractAbstract PDFSupplementary Material
Colorectal cancer is the third most common cancer in Korea and the third leading cause of death from cancer. Treatment outcomes for colon cancer are steadily improving due to national health screening programs with advances in diagnostic methods, surgical techniques, and therapeutic agents.. The Korea Colon Cancer Multidisciplinary (KCCM) Committee intends to provide professionals who treat colon cancer with the most up-to-date, evidence-based practice guidelines to improve outcomes and help them make decisions that reflect their patients’ values and preferences. These guidelines have been established by consensus reached by the KCCM Guideline Committee based on a systematic literature review and evidence synthesis and by considering the national health insurance system in real clinical practice settings. Each recommendation is presented with a recommendation strength and level of evidence based on the consensus of the committee.

Citations

Citations to this article as recorded by  
  • Optimal extent of lymph node dissection in clinical early-stage right colon cancer: a retrospective analysis
    Hyeung-min Park, Jaram Lee, Soo Young Lee, Suk Hee Heo, Yong Yeon Jeong, Hyeong Rok Kim, Chang Hyun Kim
    Annals of Surgical Treatment and Research.2025; 108(1): 49.     CrossRef
  • Effects of Microsatellite Instability on the Clinical and Pathological Characteristics of Colon Cancer and the Diagnostic Accuracy of Preoperative Abdominal CT Scans
    Rıdvan Yavuz, Orhan Aras, Hüseyin Çiyiltepe, Onur İlkay Dinçer, Ahmet Şükrü Alparslan, Tebessüm Çakır
    Diagnostics.2025; 15(2): 190.     CrossRef
  • Epigenetic Regulation of Nuclear Factor Erythroid-2-Related Factor 2 in Colorectal Cancer Cells Resistant to Ionizing Radiation
    Kyoung Ah Kang, Jinny Park, Mei Jing Piao, Pincha Devage Sameera Madushan Fernando, Herath Mudiyanselage Udari Lakmini Herath, Herath Mudiyanselage Maheshika Madhuwanthi Senavirathna, Jung-Hwan Kim, Suk Ju Cho, Jin Won Hyun
    Biomolecules & Therapeutics.2025; 33(1): 182.     CrossRef
  • Meeting report on the 8th Asian Science Editors’ Conference and Workshop 2024
    Eun Jung Park
    Science Editing.2025; 12(1): 66.     CrossRef
  • 2023 Korean Multidisciplinary Guidelines for Colon Cancer Management: Summary of Radiological Points
    Nieun Seo, Hyo Seon Ryu, Myungsu Lee, Sun Kyung Jeon, Kum Ju Chae, Joon-Kee Yoon, Kyung Su Han, Ji Eun Lee, Jae Seon Eo, Young Chul Yoon, Sung Kyung Moon, Hyun Jung Kim, Jung-Myun Kwak
    Korean Journal of Radiology.2024; 25(9): 769.     CrossRef
  • Effect of Fluorescence Lymph Node Mapping on Improving Diagnostic Values of CT D3 Lymph Node Staging for Right-Sided Colon Cancer
    Gyung Mo Son, Tae Un Kim, Mi Sook Yun, ChangYeop Kim, In Young Lee, Su Bum Park, Dong-Hoon Shin, Gi Won Ha
    Cancers.2024; 16(20): 3496.     CrossRef
  • Nuclear medicine based multimodal molecular imaging facilitates precision medicine for gastrointestinal tumors
    Jing Zhao, Fei Wang, Rong-Fu Wang
    World Chinese Journal of Digestology.2024; 32(10): 727.     CrossRef
  • Impact of Early Oral Feeding on Postoperative Outcomes after Elective Colorectal Surgery: A Systematic Review and Meta-Analysis
    Soo Young Lee, Eon Chul Han
    Digestive Surgery.2024; : 1.     CrossRef
Case Report
Benign proctology,Complication,Biomarker & risk factor
Recurrent bleeding after posthemorrhoidectomy caused by factor V deficiency: a case report and review of the literature
Jun Seong Chung, Han Deok Kwak, Jae Kyun Ju
Ann Coloproctol. 2022;38(6):449-452.   Published online July 27, 2021
DOI: https://doi.org/10.3393/ac.2021.00185.0026
  • 3,783 View
  • 145 Download
  • 1 Web of Science
  • 2 Citations
AbstractAbstract PDF
Congenital factor V (FV) deficiency is a rare hemorrhagic disorder that can cause excessive bleeding during and after surgery in the affected patient. This report is the case of a patient who had FV deficiency with recurrent posthemorrhoidectomy bleeding treated with the hemostatic procedure and fresh frozen plasma (FFP) transfusions. A 45-year-old male patient had previously undergone hemorrhoidectomy for multiple hemorrhoids at a local hospital. Hemorrhoidectomy was successful; however, he was transferred to our hospital for evaluation of the origin of the recurrent posthemorrhoidectomy bleeding and underwent a hemostatic procedure. This bleeding was treated with coagulation using electrocautery, multiple sutures, and FFP transfusion (1,600 mL/day) for 7 consecutive days. The patient’s plasma FV activity was 23%. Early detection of clotting factor deficiency in patients with hemorrhagic events after surgical treatments may prevent unnecessary procedures such as reoperations and minimize the cost of replacement therapy such as large-volume FFP transfusion.

Citations

Citations to this article as recorded by  
  • Rare Inherited Coagulation Deficiencies: A Single-center Study
    Özlem Terzi, Sadik Sami Hatipoğlu
    Journal of Pediatric Hematology/Oncology.2025; 47(2): e90.     CrossRef
  • Plasma/tranexamic-acid/vitamin-k

    Reactions Weekly.2023; 1954(1): 383.     CrossRef
Original Article
Malignant disease, Functional outcomes,Colorectal cancer
The Relationship Between High-Output Stomas, Postoperative Ileus, and Readmission After Rectal Cancer Surgery With Diverting Ileostomy
Naa Lee, Soo Young Lee, Chang Hyun Kim, Han Deok Kwak, Jae Kyun Ju, Hyeong Rok Kim
Ann Coloproctol. 2021;37(1):44-50.   Published online September 18, 2020
DOI: https://doi.org/10.3393/ac.2020.08.03
  • 4,150 View
  • 168 Download
  • 11 Web of Science
  • 9 Citations
AbstractAbstract PDF
Purpose
This study aimed to evaluate the relationship between high-output stomas (HOSs), postoperative ileus (POI), and readmission after rectal cancer surgery with diverting ileostomy.
Methods
We included 302 patients with rectal cancer who underwent restorative resection with diverting ileostomy between January 2011 and December 2015. HOSs were defined as stomas with ≥ 2,000 mL/day output. We analyzed predictive factors for readmission of these patients.
Results
Forty-eight patients (15.9%) had HOSs during the hospital stay, and 41 patients (13.6%) experienced POI. HOSs were strongly associated with POI (45.8% vs. 7.5%, P < 0.001). The all-cause readmission rate was 16.9%, with 19 (6.3%) and 20 (6.6%) experiencing ileus and acute kidney injury, respectively. HOSs (27.1% vs. 15.0%, P = 0.040) and POI (34.1% vs. 14.2%, P = 0.002) were associated with all-cause readmission, and POI was associated with readmission with ileus (17.1% vs. 4.6%, P = 0.007). POI was an independent risk factor for all-cause readmission (adjusted odds ratio [OR], 2.640; 95% confidence interval [CI], 1.162 to 6.001; P = 0.020) and readmission with ileus (adjusted OR = 3.869; 95% CI 1.387 to 10.792; P = 0.010).
Conclusion
POI was associated with readmission, particularly for subsequent ileus, in patients with diverting ileostomy. We should make efforts to reduce POI, such as strong control of HOSs, to prevent readmission.

Citations

Citations to this article as recorded by  
  • High output stoma after surgery for rectal cancer - a risk factor for low anterior resection syndrome?
    Xuena Zhang, Qingyu Meng, Jianna Du, Zhongtao Tian, Yinju Li, Bin Yu, Wenbo Niu
    BMC Gastroenterology.2025;[Epub]     CrossRef
  • Summary of Best Evidence for the Dietary Management in Patients with High-Output Ileostomy
    Ying Wang, Hua Peng, Cui Cui, Qi Zou, Mudi Yang
    Journal of Multidisciplinary Healthcare.2025; Volume 18: 877.     CrossRef
  • Maximizing Readmission Reduction in Colon Cancer Patients
    Mario Schootman, Chenghui Li, Jun Ying, Sonia T. Orcutt, Jonathan Laryea
    Journal of Surgical Research.2024; 295: 587.     CrossRef
  • Analysis of decision-making factors for defunctioning ileostomy after rectal cancer surgery and their impact on perioperative recovery: a retrospective study of 1082 patients
    Xiaojiang Yi, Huaguo Yang, Hongming Li, Xiaochuang Feng, Weilin Liao, Jiaxin Lin, Zhifeng Chen, Dechang Diao, Manzhao Ouyang
    Surgical Endoscopy.2024; 38(11): 6782.     CrossRef
  • Effect of intracorporeal anastomosis on postoperative ileus after laparoscopic right colectomy
    Sangwoo Kim, Sung Uk Bae, Woon Kyung Jeong, Seong Kyu Baek, Young-Gil Son
    Annals of Surgical Treatment and Research.2023; 104(3): 156.     CrossRef
  • The Latest Results and Future Directions of Research for Enhanced Recovery after Surgery in the Field of Colorectal Surgery
    Min Ki Kim
    The Ewha Medical Journal.2023;[Epub]     CrossRef
  • Overall readmissions and readmissions related to dehydration after creation of an ileostomy: a systematic review and meta-analysis
    I. Vogel, M. Shinkwin, S. L. van der Storm, J. Torkington, J. A.Cornish, P. J. Tanis, R. Hompes, W. A. Bemelman
    Techniques in Coloproctology.2022; 26(5): 333.     CrossRef
  • Postoperative paralytic ileus following debulking surgery in ovarian cancer patients
    Eva K. Egger, Freya Merker, Damian J. Ralser, Milka Marinova, Tim O. Vilz, Hanno Matthaei, Tobias Hilbert, Alexander Mustea
    Frontiers in Surgery.2022;[Epub]     CrossRef
  • Obstructive and secretory complications of diverting ileostomy
    Shingo Tsujinaka, Hideyuki Suzuki, Tomoya Miura, Yoshihiro Sato, Chikashi Shibata
    World Journal of Gastroenterology.2022; 28(47): 6732.     CrossRef
Editorial
Malignant disease, Rectal cancer
Is Whole-Mount Section in Rectal Cancer Effective for Measuring Lateral Margin?
Jun Seong Chung, Han Deok Kwak, Jae Kyun Ju
Ann Coloproctol. 2020;36(3):131-132.   Published online June 30, 2020
DOI: https://doi.org/10.3393/ac.2020.06.12
  • 3,143 View
  • 69 Download
  • 3 Web of Science
  • 4 Citations
PDF

Citations

Citations to this article as recorded by  
  • A comparison of whole-mount and conventional sections for pathological mesorectal extension and circumferential resection margin assessment after total mesorectal excision
    Francisco Giner, Matteo Frasson, Hanna Cholewa, Jorge Sancho-Muriel, Enrique García-Gómez, Josselyn A. Hernández, Blas Flor-Lorente, Eduardo García-Granero
    Cirugía Española (English Edition).2024; 102(8): 417.     CrossRef
  • A comparison of whole-mount and conventional sections for pathological mesorectal extension and circumferential resection margin assessment after total mesorectal excision
    Francisco Giner, Matteo Frasson, Hanna Cholewa, Jorge Sancho-Muriel, Enrique García-Gómez, Josselyn A. Hernández, Blas Flor-Lorente, Eduardo García-Granero
    Cirugía Española.2024; 102(8): 417.     CrossRef
  • MRI Assessment of Extramural Venous Invasion Before and After Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer and Its Association with Disease-Free and Overall Survival
    Hannah M. Thompson, David D. B. Bates, Jennifer Golia Pernicka, Sun Jin Park, Mahra Nourbakhsh, James L. Fuqua, Megan Fiasconaro, Jessica A. Lavery, Iris H. Wei, Emmanouil P. Pappou, J. Joshua Smith, Garrett M. Nash, Martin R. Weiser, Philip B. Paty, Juli
    Annals of Surgical Oncology.2023; 30(7): 3957.     CrossRef
  • Large-Section Histopathology Can Better Indicate the Immune Microenvironment and Predict the Prognosis of Pancreatic Ductal Adenocarcinoma Than Small-Section Histopathology
    Guiling Ding, Meng Guo, Yelin Yang, Chen Sun, Shengyong Wu, Xingchen Liu, Jin Wang, Hui Jiang, Yanfang Liu, Jianming Zheng
    Frontiers in Oncology.2021;[Epub]     CrossRef
Case Report
Malignant disease, Rectal cancer
Laparoscopic Resection of a Huge Retrorectal Tumor
Han Deok Kwak, Jae Kyun Ju
Ann Coloproctol. 2020;36(1):54-57.   Published online February 29, 2020
DOI: https://doi.org/10.3393/ac.2018.07.31.1
  • 3,810 View
  • 103 Download
  • 5 Web of Science
  • 6 Citations
AbstractAbstract PDF
Retrorectal space tumors are rare, and so are frequently unrecognized, misdiagnosed, and mistreated. A 57-year-old man visited the outpatient clinic with the chief complaints of thin stool and lower pelvic heaviness. A smooth, round huge palpable mass on the right posterolateral rectal wall was detected and pelvic computed tomography showed a 7.8-cm cystic lesion in the right retrorectal space. Laparoscopic procedures were initiated with perirectal dissection for rectal mobilization. After fixation of the peritoneum and tying the rectum for intracorporeal traction, the rectum was mobilized to identify the cyst. The cyst was removed using an endo-bag, with completion of cyst dissection. The final pathologic diagnosis was a tailgut cyst, or retrorectal cystic hamartoma without evidence of malignancy. The patient was discharged without any complications. The patient had no dyschezia or problems with bowel function. Laparoscopic resection is a safe and feasible method for surgical treatment, even for bulky retrorectal tumors, with an early recovery period.

Citations

Citations to this article as recorded by  
  • Tailgut Cyst—Gynecologist’s Pitfall: Literature Review and Case Report
    Andrei Mihai Malutan, Viorela-Elena Suciu, Florin Laurentiu Ignat, Doru Diculescu, Razvan Ciortea, Emil-Claudiu Boțan, Carmen Elena Bucuri, Maria Patricia Roman, Ionel Nati, Cristina Ormindean, Dan Mihu
    Diagnostics.2025; 15(1): 108.     CrossRef
  • Intraoperative endoscopic ultrasound‐guided robotic retrorectal dermoid cyst excision—A video vignette
    Piercarmine Panzera, Francesco Vittore, Francesco Paolo Prete, Giuseppe Massimiliano De Luca, Silvia Malerba, Nicola Tartaglia, Arianna Pontrelli, Enrico Fischetti, Angela Gurrado, Mario Testini
    Colorectal Disease.2025;[Epub]     CrossRef
  • Surgical outcomes after reoperation for patients with recurrent presacral tumors: a retrospective study
    Rui Li, Zhiyuan Yu, Jiahu Ye, Xin Liu, Peiyu Li, Xudong Zhao
    World Journal of Surgical Oncology.2024;[Epub]     CrossRef
  • Total Laparoscopic Excision of a Large Tailgut Cyst
    Ajay Nimbalkar, Anand Zingade, Balaji Dhaigude
    Cureus.2024;[Epub]     CrossRef
  • Epidemiology, diagnostic approach and therapeutic management of tailgut cysts: A systematic review
    Aikaterini Mastoraki, Ilias Giannakodimos, Karmia Panagiotou, Maximos Frountzas, Dimosthenis Chrysikos, Stylianos Kykalos, Georgios E. Theodoropoulos, Dimitrios Schizas
    International Journal of Clinical Practice.2021;[Epub]     CrossRef
  • Robotic approach to large tailgut cyst with malignant transformation: A case report
    Alessandra Marano, Maria Carmela Giuffrida, Chiara Peluso, Valentina Testa, Paolo Bosio, Felice Borghi
    International Journal of Surgery Case Reports.2020; 77: S57.     CrossRef
Original Articles
Malignant disease
Thirty-Day Readmission After Elective Colorectal Surgery for Colon Cancer: A Single-Center Cohort Study
Jun Seong Chung, Han Deok Kwak, Jae Kyun Ju
Ann Coloproctol. 2020;36(3):186-191.   Published online January 31, 2020
DOI: https://doi.org/10.3393/ac.2019.11.04
  • 4,269 View
  • 114 Download
  • 9 Web of Science
  • 10 Citations
AbstractAbstract PDF
Purpose
There is a concern that enhanced recovery after surgery may affect other proposed quality measures, including the rate of readmission due to early discharge. We examine the 30-day readmission rate, risk factors associated with readmission after elective colorectal surgery for colon cancer, causes of readmission, disease-free survival (DFS), and overall survival (OS) in a single institution.
Methods
We retrospectively investigated 292 patients who underwent elective colorectal surgery for colon cancer between 2010 and 2015. Baseline data including age, sex, body mass index, American Society of Anesthesiologists physical status classification, preoperative comorbidities, previous operation history, TNM stage, surgical approach, operation time, gas passage time, and length of hospital stay were obtained. Univariate and multivariate logistic regression analyses were performed to identify risk factors associated with 30-day readmission.
Results
A total of 229 patients who underwent elective colorectal surgery were enrolled. Twenty-four patients were readmitted 30 days after discharge. The most common readmission diagnoses were wound bleeding or surgical site infection. Multivariate analysis indicated that patients who had preoperative hepatic disease were at the highest risk of readmission (odds ratio [OR], 8.98; 95% confidence interval [CI], 7.35–10.61). Survival outcomes were significantly better in the nonreadmitted group (OS, P=0.00; DFS, P=0.04).
Conclusion
This study identified that preoperative comorbidities including hepatic and pulmonary diseases were associated with higher readmission rates after elective colorectal surgery. Moreover, the most common cause of readmission in patients who underwent elective colorectal surgery was wound bleeding or surgical site infection.

Citations

Citations to this article as recorded by  
  • Cost-effectiveness and readmission rates of laparoscopic vs. open surgery for colorectal cancer: evidence from the health insurance review and assessment service dataset in South Korea
    Sanghyun An, Sung Eun Hong, Moo Hyun Kim, Ik Yong Kim
    Frontiers in Surgery.2025;[Epub]     CrossRef
  • Risk factors for unplanned 31-day readmission after surgery for colorectal cancer patients: a meta-analysis
    Nan Qu, Tiantian Li, Lifeng Zhang, Xingyu Liu, Liping Cui
    BMC Gastroenterology.2025;[Epub]     CrossRef
  • Readmission rates following major colorectal surgery
    Aoife Shorten, Matthew G. Davey, William P. Joyce
    The Surgeon.2024; 22(2): 116.     CrossRef
  • Ambulatory Robotic Colectomy: Factors Affecting and Affected by Postoperative Opioid Use
    Michael M. Vu, Jace J. Franko, Anna Buzadzhi, Beau Prey, Maksim Rusev, Marta Lavery, Laila Rashidi
    Surgical Laparoscopy, Endoscopy & Percutaneous Techniques.2024; 34(2): 163.     CrossRef
  • Meta-analysis of postoperative incision infection risk factors in colorectal cancer surgery
    Li Jia, Huacai Zhao, Jia Liu
    Frontiers in Surgery.2024;[Epub]     CrossRef
  • The 30-day readmission rate of patients with an overlap of probable sarcopenia and malnutrition undergoing major oncological surgery
    Hadassa Hillary Novaes Pereira Rodrigues, Kathyelli Thaynara Pimenta de Araujo, José Eduardo de Aguilar-Nascimento, Diana Borges Dock-Nascimento
    einstein (São Paulo).2024;[Epub]     CrossRef
  • Risk factors for early readmission to hospital in patients with malignancy-related ascites: a retrospective cohort study
    Zhenhua Tian, Zhilong Huang, Yaqi Guo, Xiaolin Zhao, Luna Liu, Chunxiao Yu, Qingbo Guan
    Frontiers in Oncology.2024;[Epub]     CrossRef
  • A National Cancer Database analysis of the predictors of unplanned 30-day readmission after proctectomy for rectal adenocarcinoma: The CCF RETURN-30 Score
    Sameh Hany Emile, Nir Horesh, Michael R. Freund, Zoe Garoufalia, Rachel Gefen, Emanuela Silva-Alvarenga, Steven D. Wexner
    Surgery.2023; 173(2): 342.     CrossRef
  • Data analytics and artificial intelligence in predicting length of stay, readmission, and mortality: a population-based study of surgical management of colorectal cancer
    Shamsul Masum, Adrian Hopgood, Samuel Stefan, Karen Flashman, Jim Khan
    Discover Oncology.2022;[Epub]     CrossRef
  • The 30-day hospital readmission and mortality after surgery in colorectal cancer patients
    Mesnad S. Alyabsi, Anwar H. Alqarni, Latifah M. Almutairi, Mohammed A. Algarni, Kanan M. Alshammari, Adel Almutairi, Nahar A. Alselaim
    BMC Gastroenterology.2022;[Epub]     CrossRef
Immunological Differences Between Right-Sided and Left-Sided Colorectal Cancers: A Comparison of Embryologic Midgut and Hindgut
Han Deok Kwak, Jae Kyun Ju
Ann Coloproctol. 2019;35(6):342-346.   Published online December 31, 2019
DOI: https://doi.org/10.3393/ac.2019.03.17.1
  • 4,007 View
  • 96 Download
  • 8 Web of Science
  • 8 Citations
AbstractAbstract PDF
Purpose
There are known differences in embryology, clinical symptoms, incidences, molecular pathways involved, and oncologic outcomes of right-sided and left-sided colorectal cancers. However, immunologic study has only been characterized for healthy adults. The present study was designed to identify differences in immune cell populations in patients with right-sided and left-sided colorectal cancers.
Methods
A total of 35 patients who underwent colorectal resection for cancer between November 2016 and August 2017 at a tertiary teaching hospital were enrolled in this study. Patients were excluded if they had a disease affecting their immune system. Populations of immune cells, including mucosal-associated invariant T (MAIT), gamma delta T, invariant natural killer T, T, natural killer, and B cells, were measured in the peripheral blood and cancer tissues using flow cytometry, and then assessed based on the origin of the colorectal cancer.
Results
Fifteen had right-side and 20 had left-side colorectal cancer. There were no significant differences between the 2 cohorts for patient characteristics including pathologic stage. Peripheral blood from patients with right-side colon cancers contained fewer MAIT (0.87% right-side vs. 1.74% left-side, P = 0.028) and gamma delta T cells (1.10% right-side vs. 3.05% left-side, P = 0.002). Although the group with right-side colorectal cancer had more MAIT cells in cancer tissues (1.71% vs. 1.00%), this difference was not statistically significant.
Conclusion
There is a difference in population sizes of immune cells in blood between patients with right-sided and leftsided colon cancers. The immune cell composition was determined to be distinct based on embryologic origin.

Citations

Citations to this article as recorded by  
  • Survival of Patients with Right-Sided and Left-Sided Colon Cancer: Insights from an Iranian Medical Center
    Alimohammad Bananzadeh, Sara Shojaei-Zarghani, Amir Reza Bahadori, Ali Reza Safarpour
    Shiraz E-Medical Journal.2024;[Epub]     CrossRef
  • Advancements in immunotherapy for colorectal cancer treatment: a comprehensive review of strategies, challenges, and future prospective
    Vaishak Kaviyarasan, Alakesh Das, Dikshita Deka, Biki Saha, Antara Banerjee, Neeta Raj Sharma, Asim K. Duttaroy, Surajit Pathak
    International Journal of Colorectal Disease.2024;[Epub]     CrossRef
  • Intertwined leukocyte balances in tumours and peripheral blood as robust predictors of right and left colorectal cancer survival
    Ramón Cantero-Cid, Karla Marina Montalbán-Hernández, Jenny Guevara, Alejandro Pascual-Iglesias, Elisa Pulido, José Carlos Casalvilla, Cristóbal Marcano, Cristina Barragán Serrano, Jaime Valentín, Gloria Cristina Bonel-Pérez, José Avendaño-Ortiz, Verónica
    World Journal of Gastrointestinal Oncology.2022; 14(1): 295.     CrossRef
  • Epidemiology, risk factors, and prevention of colorectal cancer
    Kyung Uk Jung, Hyung Ook Kim, Hungdai Kim
    Journal of the Korean Medical Association.2022; 65(9): 549.     CrossRef
  • Epidemiology, Risk Factors, and Prevention of Colorectal Cancer-An English Version
    Kyung Uk Jung, Hyung Ook Kim, Hungdai Kim
    Journal of the Anus, Rectum and Colon.2022; 6(4): 231.     CrossRef
  • Variants of creating heterotopic and orthotopic PDX models of human colorectal cancer
    A. A. Kiblitskaya, A. Y. Maksimov, A. S. Goncharova, Ye. M. Nepomnyashchaya, Ye. Y. Zlatnik, G. Y. Yegorov, Ye. A. Lukbanova, Ye. V. Zaikina, A. V. Volkova
    Bulletin of Siberian Medicine.2022; 21(3): 50.     CrossRef
  • Genotypic and Phenotypic Characteristics of Hereditary Colorectal Cancer
    Jin Cheon Kim, Walter F. Bodmer
    Annals of Coloproctology.2021; 37(6): 368.     CrossRef
  • Laterality: Immunological Differences Between Right-Sided and Left-Sided Colon Cancer
    Seong Kyu Baek
    Annals of Coloproctology.2019; 35(6): 291.     CrossRef
Editorial
Tailgut Cyst, Report of 24 Cases Single Center Experience
Han Deok Kwak, Chang Hyun Kim
Ann Coloproctol. 2019;35(5):227-228.   Published online October 31, 2019
DOI: https://doi.org/10.3393/ac.2019.10.14
  • 3,598 View
  • 94 Download
  • 2 Web of Science
  • 2 Citations
PDF

Citations

Citations to this article as recorded by  
  • Minimally invasive approach for retrorectal tumors above and below S3: a multicentric tertiary center retrospective study (MiaRT study)
    T. Bardol, R. Souche, C. Druet, M. M. Bertrand, C. Ferrandis, M. Prudhomme, F. Borie, J.-M. Fabre
    Techniques in Coloproctology.2024;[Epub]     CrossRef
  • Open surgical treatment for giant presacral tailgut cyst – a case report
    Q Liu, P Guo, C Li, G Yu, J Jiao
    South African Journal of Surgery.2024; 62(4): 358.     CrossRef
  • FirstFirst
  • PrevPrev
  • Page of 1
  • Next Next
  • Last Last

Ann Coloproctol : Annals of Coloproctology Twitter Facebook
TOP